11/20/09

Blue Marble Snags $2M State Grant

Seattle-based Blue Marble Energy, the developer of renewable energy and specialty chemicals from biomass, said it has received a $2 million state grant through a partnership with the Odessa Public Development Authority. The company plans to use the grant, from the Washington Community Economic Revitalization Board, to build a refinery in Lincoln County that will turn organic biomass from around Eastern Washington into as much as 858 metric tons of biochemicals and 700 metric tons of green ammonia per year, says CEO Kelly Ogilvie, in an e-mail. The facility is expected to create 30 to 50 full-time jobs in its first year, he says.

SS&C Buys TheNextRound

TheNextRound, a Framingham, MA-based startup that makes software for private equity and alternative investors, has been acquired by Windsor, CT-based SS&C Technologies for an undisclosed amount, according to an SS&C announcement today. SS&C makes financial management software for insurance companies, hedge funds, banks and credit unions, real estate companies, and other institutions.

$31.3M for Cambridgesoft

Cambridge, MA-based Cambridgesoft, which makes software for life sciences companies, disclosed in regulatory documents filed November 17 that it has raised $31.3 million in new equity-based financing. Cambridgesoft first announced the funding round (though not the amount) in a November 16 release that named new investor Health Evolution Partners and existing investor Goldman Sachs as the funders in the round.

Dendreon FDA Deadline Set For May 1

Seattle-based Dendreon (NASDAQ: DNDN), the developer of what it hopes will be the first FDA-approved treatment to actively stimulate the immune system against cancer, said today the U.S. regulatory agency has received its amended application and set a deadline of May 1, 2010 to complete its review. The company is seeking clearance to start selling sipuleucel-T (Provenge) for men with prostate cancer that’s no longer controlled by standard chemical castration therapies. The application includes data from a 512-patient study which showed the drug could extend lives by a median of four months when compared with a placebo.

Brown, IBM Switch On Supercomputer

A new IBM supercomputer opened at Brown University’s Center for Computation and Visualization in Providence, RI, today is 50 times faster than Brown’s next best machine and is the most powerful computer in Rhode Island, according to an announcement from IBM (NYSE: IBM). Researchers at Brown and other institutions intend to use the 1,440-processor machine to model subjects such as the genomes of ocean-going microbes, the mechanics of human and animal movement, and the topography of other planets. Brown ordered the multimillion-dollar supercomputer in June; its exact cost hasn’t been disclosed, but IBM and Brown are calling it “a shared investment.”

11/19/09

17 New Web Startups Around Town

At least 17 Seattle-area startups rolled out new websites last month, according to the latest edition of Seattle 2.0’s startup index. The index now lists 373 companies, which are ranked on the basis of Web traffic estimates. The top 10 sites didn’t change much from previous months. The startups that are new to the list are HasOffers, BigStartups, Team Apart, Boxoh.com, EnergySavvy.com, Couchsoft (Mentby), Osnapz, Social Kind (TweetToCall, Escape My Date), Fotozio (PicTranslator), Adometry (Veracity), Qbiki Networks (iPhoneSeattle), HotelsOutlook, BuzzMinder (2Reminders), Splitts.com, Data Applied, Baldy Beanbag (The Big Magoo), and Megosi.

ImmunoGen Nabs $1M From Amgen

Waltham, MA-based ImmunoGen (NASDAQ: IMGN) said today that Amgen has purchased a second license to develop a treatment that uses ImmunoGen’s technology for linking targeted antibodies to cell-killing agents that make them more potent. ImmunoGen will get $1 million upfront and could receive $34 million worth of milestone payments over time if Amgen is successful in developing a drug against an undisclosed target on cancer cells. Amgen bought its first such license to the ImmunoGen technology in September.

Cozi Teams Up with MWV

Seattle-based Cozi announced today it has formed a strategic partnership with MeadWestvaco (NYSE: MWV), a Sidney, NY-based maker of school and office supplies and planning tools. Financial terms of the deal weren’t announced, but the partnership will give MWV consumers access to Cozi’s Web-based software for helping families manage their busy schedules. The tools include a family calendar, customized to-do lists, and messaging systems. This is the third partnership Cozi will announce with a Fortune 500 company this year, including a previous deal with Dell to pre-load certain home computers with Cozi’s software.

$5.3M for Corindus

Natick, MA-based Corindus has corralled $5.3 million of a proposed $10 million round of equity financing, according to an SEC filing. The firm is developing a robotic system that helps surgeons control the position of guidewires in veins in procedures to implant vascular stents, according to the firm’s LinkedIn profile. A call to company CEO David Handler was not immediately returned today, and it’s not stated in the SEC filing who participated in the financing. Prior to this financing, the firm raised $12.8 million in a Series B financing in spring 2008, according to a story I wrote about the deal for Mass High Tech.

Ligon Discovery Seeded with $1M

Ligon Discovery reported today on its website that it has raised $1 milllion in seed financing from incTANK Ventures. The Cambridge, MA-based startup says it uses a small molecule microarray system developed at Harvard University to discover drugs, and the drug-discovery technology has already been put to work at the Broad Institute. The company founders include Benjamin Ebert of Harvard Medical School, Angela Koehler of the Broad Institute, and company CEO Patrick Kleyn, who was previously director of scientific planning at the Broad. As part of the financing, IncTank Ventures general partner Christian Bailey is joining the board of directors at Ligon, according to the company.

New Partner at Braemar Energy Ventures

Braemar Energy Ventures, a venture firm focused on investments in the cleantech sector, has named Jiong Ma a partner of the firm, according to a Mass High Tech report. She was previously a principal at the firm, which has offices in Boston and New York City, according to its website. Braemar’s portfolio includes such Boston-area cleantech companies as A123 Systems (NASDAQ:AONE), EnerNOC (Nasdaq:ENOC), and Verenium (NASDAQ:VRNM).

Ligand Nabs $2M From Merck

San Diego-based Ligand Pharmaceuticals (NASDAQ: LGND) said today it has received $2 million in milestone payments as part of research collaboration with Merck that is due to expire next month. The partnership started with Organon, which was later acquired by Schering-Plough, which was then acquired by Merck.

11/18/09

Sony Ericsson Closing SD Operation

Sony Ericsson says it plans to close its operations in San Diego as part of a global consolidation that the cell phone handset maker announced today. The London-based joint venture between Sweden’s LM Ericsson and Japan’s Sony Corp plans to move its North American headquarters from Research Triangle, NC, to Atlanta, and consolidate its product development operations by closing sites in six locations—San Diego; Research Triangle, NC; Seattle; Miami; Kista, Sweden; and Chennai, India. About 1,600 jobs are being eliminated.

Sony Ericsson Closing Bellevue Office

Sony Ericsson, the London-based mobile handset maker, is shutting its Seattle-area office, as first reported by Engadget and Triangle Business Journal. Sony Ericsson is cutting about 2,000 out of 9,900 jobs globally, including closing offices in Research Triangle Park, San Diego, Miami, Kista, Sweden, and Chennai, India. The moves are part of a company-wide restructuring that includes moving its North American headquarters from Research Triangle Park to Atlanta, GA.

Voyager Re-ups with Placecast

Seattle-based Voyager Capital has participated in a $5 million investment in 1020, the San Francisco developer of Placecast, a location-based advertising and marketing platform, according to a report in TechCrunch. Quatrex Capital and Onset Ventures also participated in the Series B funding, which will be used to accelerate Placecast’s technology development. Placecast’s algorithms combine data across the Web, mobile, e-mail, and Wi-Fi to try to maximize relevance for advertisers and publishers. In an interview with Xconomy last year, Voyager co-founder Enrique Godreau mentioned 1020 as an example of an intriguingly mainstream mobile startup.

11/17/09

NextImage Medical Raises $5M

San Diego’s NextImage Medical, Inc., which has developed a Web-based system for scheduling and managing diagnostic imaging services, says it has raised $5 million in Series A funding in a round led by Chrysalis Ventures of Louisville, KY. Liz Griggs founded NextImage Medical last year as a way to provide high-quality, low-cost radiology services, either through insurers, self-insured employers, or direct-to-consumer. A statement from NextImage Medical says Griggs previously was the founder of New Jersey-based One Call Medical, a radiology preferred provider organization (PPO) that was sold in 2003 for $115 million.

11/16/09

Report: SEC Probing 3Com for Potential Insider Trading

The Securities and Exchange Commission is investigating whether a surge in call option trading on 3Com shares just hours before the announcement that Hewlett-Packard would take over the Marlborough, MA-based networking equipment maker for $2.7 billion was a result of insider knowledge of the deal, Bloomberg and other outlets are reporting today. Trading in call options—which guarantee the right to acquire a stock at a certain price—hit a 26-month high on November 11, just before the after-hours announcement of the acquisition. That “screams insider trading to the SEC,” Wayne State University law professor and former SEC attorney Peter Henning told Bloomberg, whose report was based on information from an unnamed source inside the agency.

DocuSign Scores Second Century Investment

Seattle-based DocuSign announced today it has received a strategic investment from Second Century Ventures, the VC fund of the National Association of Realtors. The amount was undisclosed, but the cash will be used to speed up and extend DocuSign’s efforts with residential and commercial real estate customers. DocuSign was founded in 2003 and makes software to automate and control the process of electronic signatures.

$875K for Swipely

Swipely, a Providence, RI-based startup that was quietly launched earlier this year, has raised $875,000 of a planned $1 million equity financing, according to an SEC document filed last week. Angus Davis—a co-founder of the voice-based Internet search and services provider Tellme Networks, which was sold to Microsoft (NASDAQ:MSFT) and became a subsidiary of the Redmond, WA-based software giant in 2007—is listed as an executive and director of the startup. Davis told Mass High Tech in a story this morning that First Round Capital, of Philadelphia and San Francisco, led the financing in Swipely. He declined to describte to MHT, or when reached by phone this afternoon, what his startup is doing.

Alkermes to Seek FDA Approval of Anti-Addiction Drug

Cambridge,MA-based biotech Alkermes said this morning that its long-acting naltrexone injection (Vivitrol) was more effective in treating opioid drug dependence than placebo in a Phase III clinical trial. The 250-patient clinical trial compared urine samples of patients who took the firm’s once-per-month injection of naltrexone versus those who took placebo over the last 20 weeks of a 24-week treatment period. Alkermes (NASDAQ:ALKS) said that it plans to file an application with the FDA for approval of its drug for treating opioid dependence in the first half of 2010. The FDA approved the drug for treating alcohol dependence in 2006.